	DECIPHER-PRAD: an advanced fragmentomics-based cell-free DNA assay for prostate cancer early detection. Cell Commun Signal Zhang S, Zhu G, Xu L, Zhang Q, Qiu X, Bao H, Wu M, Zhao X, Ding T, Wang F, Chang S, Shao Y, Zhuang J, Guo H. PMID: 41318553 [PubMed - as supplied by publisher]
	Global, regional, and national bladder cancer burden from 1990 to 2021 and forecasts to 2050: a systematic analysis of the global disease burden study in 2021. BMC Public Health Feng W, Wang Y, Wu K, Zeng J, Zhou Q, Tan X, Deng X, Zheng R, Huang L, Li X, Yao K, Wu Z. PMID: 41318429 [PubMed - as supplied by publisher]
	Comment on "high-dose-rate (HDR) brachytherapy boost in combination with external beam radiotherapy for localized prostate cancer: An evidence-based consensus statement". Brachytherapy Dedeepya SD, Goel V, Desai NN. PMID: 41318308 [PubMed - as supplied by publisher]
	Health Literacy, Self-Management and Patient-Reported Outcomes in Prostate Cancer Survivors: A Mixed Methods Systematic Review. Semin Oncol Nurs Sheehan S, Bernués-Caudillo L, de Brún A, Drury A. PMID: 41318285 [PubMed - as supplied by publisher]
	Extending Current Guideline-recommended Prostate-specific Antigen Density Thresholds for Improving Benefit/Harm Balance in Risk-based Magnetic Resonance Imaging-directed Prostate Cancer Diagnosis, from the Community-based Multicentre MR-PROPER Study. Eur Urol Oncol Prinsen AMA, Wagensveld IM, Osses DF, Groenendijk PM, Zijta FM, Busstra MB, Rociu E, Barentsz JO, Sedelaar JPM, Arbeel B, Roeleveld T, Geenen R, Koeter I, van der Meer S, Cappendijk VC, Klaver S, van der Lely H, Wolters T, Leter MR, van der Poel HG, Heijmink SWTPJ, Immerzeel J, Leijte JAP, van Roermund JGH, Miclea RL, Planken E, Vis AN, de Jong IJ, Tijsterman J, Wolterbeek D, Claessen A, Nederend J, Bangma CH, Roobol MJ, Remmers S, van den Bergh RCN, Somford DM, Schoots IG. PMID: 41318235 [PubMed - as supplied by publisher]
	Re: Markus Graefen, Fabian Falkenbach, Tobias Maurer, et al. Best Systemic Therapy With or Without Radical Prostatectomy in the Management of Men With Oligometastatic Prostate Cancer: The RAMPP Randomised Controlled Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.09.4144. Eur Urol Oncol Huck C, Sargos P, Bossi A. PMID: 41318234 [PubMed - as supplied by publisher]
	Optimizing Biopsy Decisions in PI-RADS 3-4 Lesions: Integrating PSA-derived Biomarkers to Reduce Unnecessary Procedures. Anticancer Res Kuo JH, Ou YC, Hu CY, Wu KY, Liu CJ, Lu ZH, Jan HC, Lin KC, Hsieh YC, Ou CH, Tsai YS. PMID: 41318146 [PubMed - indexed for MEDLINE]
	Should Upfront Therapy With Androgen Receptor Signaling Inhibitors Be Used in All Japanese Patients With Metastatic Castration-sensitive Prostate Cancer? Anticancer Res Onishi K, Nakai Y, Miyake M, Matsumura Y, Onishi M, Sakamoto K, Hajikano S, Iemura Y, Haramoto M, Maesaka F, Hirao S, Yoshida T, Inoue K, Saka T, Iwamoto T, Hosokawa Y, Iida K, Itami Y, Fujimoto K, Tanaka N. PMID: 41318135 [PubMed - indexed for MEDLINE]
	Renal Function With Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study in Japan. Anticancer Res Kobari Y, Iizuka J, Kondo H, Ichioka M, Watanabe S, Nakamura K, Nemoto Y, Horiuchi T, Mizoguchi S, Yoshida K, Shimmura H, Hashimoto Y, Kondo T, Kobayashi H, Takagi T. PMID: 41318114 [PubMed - indexed for MEDLINE]
	Feasibility of transperineal prostate biopsy guided by fusion of [18F]F-PSMA-1007 PET/MRI with real-time transrectal ultrasound. Prostate cancer classification using imaging biomarkers and radiomics in PIRADS 3 lesions. Rev Esp Med Nucl Imagen Mol (Engl Ed) Garcia JR, Garrido N, Bassa P, Compte A, Pinilla L, Romero JA, Mont LL, Garcia J, Ruiz S, Mourelo S, Santabárbara JM, Riera E. PMID: 41317899 [PubMed - as supplied by publisher]
	Molecular targeted therapies, omics, and AI based theranostics approaches for the treatment of prostate cancer. Talanta Khan S, Nema P, Kashaw V, Kashaw SK. PMID: 41317478 [PubMed - as supplied by publisher]
	Postchemotherapy phenotypes of GCNIS-derived testicular germ cell tumors, focusing on yolk sac tumor variants, trophoblastic tumors, and somatic-type malignancies. Semin Diagn Pathol Collins K, Acosta AM, Idrees MT, Ulbright TM. PMID: 41317416 [PubMed - as supplied by publisher]
	Real-world evidence of nivolumab monotherapy in advanced renal cell carcinoma from a multicenter retrospective cohort study by the Spanish Genitourinary Oncology Group. BMC Cancer Fernández-Díaz N, Mateos-González M, Pertejo-Fernández A, Cacho-Lavín JD, Juan-Fita MJ, Chirivella-González I, Arruti-Ibarbia M, Fernández-Calvo O, Fernández-Núñez N, Méndez-Vidal MJ, Lázaro-Quintela M, Molina-Díaz A, Del Pozo-Alonso N, Etxaniz-Ulazia O, García-Acuña SM, Betancor YZ, Azueta-Etxebarria A, Calatrava-Fons A, Lombardía-Rodríguez H, Alarcón-Molero L, Etxegarai-Ganboa L, Antón-Cameselle A, Bello-Giz JA, Neira-De Paz CM, Cabaleiro T, González-Serrano T, Ortiz-Rey JA, Sacristán-Lista F, García-Rubín S, Ortega E, Carrato-Moñino C, Aguín-Losada S, León-Mateos L, García-González J, Pinto-Marín Á, Duran I, López-López R, Anido-Herranz U, Ruiz-Bañobre J. PMID: 41316036 [PubMed - indexed for MEDLINE]
	Ultrasensitive electrochemical biosensor based on MXene quantum dots for prostate cancer biomarker detection. Sci Rep Safarpoor M, Asfaram A, Ghaedi M, Dinarvand R. PMID: 41315352 [PubMed - indexed for MEDLINE]
	Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer. Cancer Chemother Pharmacol Perimbeti S, Jamroze A, Gopalakrishnan D, Jain R, Jiang C, Holleran JL, Parise RA, Bies R, Quinn D, Attwood K, Liu X, Green K, Kirk JS, Beumer JH, Tang DG, Chatta G. PMID: 41315064 [PubMed - indexed for MEDLINE]
	Low-dose abiraterone acetate for the treatment of prostate cancer: An observational cohort study. Farm Hosp Di-Giuseppe LA, Ramirez-Murillo RA, Aymar MD, Basbus LR, Cornec M, Terrasa SA, Posadas-Martínez ML, Burgos MA, Buela G, Cayol F. PMID: 41314925 [PubMed - as supplied by publisher]
	Bladder EpiCheck triggered Photodynamic Diagnosis biopsies Detect High-grade Bladder Cancer Recurrences Missed by White Light Cystoscopy. Eur Urol Oncol Mariappan P, Hart-Brooke J, Sparks R, Lord-McKenzie T. PMID: 41314886 [PubMed - as supplied by publisher]
	Assessing risk stratification in Bacillus Calmette-GuÃ©rin-treated high-grade Ta nonmuscle-invasive bladder cancer patients. Urol Oncol Finocchiaro A, Contieri R, Piccolini A, Brin P, Moretto S, Dagnino F, Aljoulani M, Uleri A, Avolio P, Beatrici E, Mancon S, Paciotti M, Fasulo V, Saita A, Casale P, Lughezzani G, Buffi N, Lazzeri M, Hurle R. PMID: 41314879 [PubMed - as supplied by publisher]
	Comparison of spinal versus general anaesthesia in high-risk non-muscle invasive bladder cancer: study protocol for a randomised controlled trial. BMJ Open Fang CW, Shau WY, Fan SZ, Chueh JS. PMID: 41314851 [PubMed - indexed for MEDLINE]
	Spatial patterns of testicular cancer diagnosis in Australia, 2010-2019. Spat Spatiotemporal Epidemiol Bainomugisa CK, Dasgupta P, Cameron JK, Tran B, Cramb SM, Baade PD. PMID: 41314725 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 174327

Page 1 of 8717



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy